Two Boston physicians lauded for tenures on AHA national board

Drs. Joseph Loscalzo and Lee Schwamm are among four physicians being recognized this week as their terms on the American Heart Association’s National Board of Directors come to an end.

Both Loscalzo and Schwamm teach at Harvard Medical School. Loscalzo is also chairman of the Department of Medicine and physician-in-chief at Brigham and Women’s Hospital; Schwamm is also vice chairman of neurology at Massachusetts General Hospital.

In an email to American Heart Association staff, association CEO Nancy Brown said Loscalzo and Schwamm are “among the brain trust of the American Heart Association.”

Loscalzo and Schwamm are being recognized alongside the board’s immediate past president Dr. Mitchell Elkind and Dr. Mary Ann Bauman, whose terms on the national board also ended with the start of the new fiscal year on July 1.

“We thank these incredible leaders for their contributions of time, talent and passion as national board members, and we look forward to the many ways they will continue to champion the AHA mission,” Brown said.

In her email, Brown summarized Loscalzo’s and Schwamm’s recent contributions to the American Heart Association as follows:

Dr. Lee Schwamm
“Lee has served as chair of the American Stroke Association Advisory Committee for the past three years — guiding the association’s efforts through the COVID-19 pandemic and accelerating our adoption of “digital first” strategies that prioritize health equity, especially in stroke and telehealth-enabled approaches to care. He was instrumental to the development of the Get With The Guidelines® hospital quality improvement program alongside Dr. Gregg Fonarow and Dr. Clyde Yancy — all of whom received this year’s Gold Heart Award, the AHA’s highest volunteer honor.”

Dr. Joseph Loscalzo
“Joe was vital to the design and implementation of the AHA’s strategic direction in research, scientific publishing and precision medicine. His vision informs the AHA’s Institute for Precision Cardiovascular Medicine, One Brave Idea, Strategically Focused Research Networks and our groundbreaking partnership with the Lawrence Livermore National Laboratory.”